Related Experiment Videos
Hypertrophic cardiomyopathy and myocardial ischemia with normal coronary arteries
Insights
This study details a rare case of hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome, showing localized heart muscle thickening and ischemia despite clear coronary arteries. The findings suggest a functional blood flow issue rather than a blockage.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
- Nuclear Cardiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition often associated with various arrhythmias and ischemic events.
- Wolff-Parkinson-White (WPW) syndrome is a pre-excitation syndrome that can predispose individuals to supraventricular tachycardias.
- Myocardial ischemia in the absence of obstructive coronary artery disease presents a diagnostic challenge.
Observation:
- A unique case of nonobstructive hypertrophic cardiomyopathy is presented, coexisting with Wolff-Parkinson-White syndrome.
- The patient exhibited myocardial ischemia and necrosis, notably with normal coronary arteries.
- A distinctive feature was the exclusive localization of myocardial hypertrophy to the posterolateral free wall.
Findings:
- Quantitative thallium-201 scintigraphy revealed reversible ischemia.
- The ischemic region precisely corresponded to the area of posterolateral myocardial hypertrophy.
- This correlation suggests a localized functional disturbance of myocardial blood flow.
Implications:
- The case highlights an unusual presentation of hypertrophic cardiomyopathy and its association with WPW syndrome and ischemia.
- It supports the hypothesis that functional, rather than anatomical, disturbances in coronary blood flow may underlie ischemia in some HCM patients.
- Further research into the mechanisms of myocardial ischemia in HCM with normal coronary arteries is warranted.
Abstract:
The case reported herein illustrates an unusual form of nonobstructive hypertrophic cardiomyopathy which was associated with Wolff-Parkinson-White syndrome, myocardial ischemia and necrosis despite normal coronary arteries. The patient is unique since the hypertrophied myocardial segment was localized exclusively to the posterolateral free wall. Quantitative thallium-201 scintigraphy demonstrated reversible ischemia that corresponded precisely with this region of posterolateral hypertrophy. While the exact mechanism for ischemia in patients with hypertrophic cardiomyopathy and normal coronary arteries remains controversial, a functional rather than anatomic disturbance of blood flow seems likely.